DEK and acute myeloid leukemia: To the best of our knowledge, it is not whether or how extracellular DEK shows posttranscriptional modification, but if CXCR2 ligation by DEK or the DEK-NUP214 fusion protein has any role in AML leukemogenesis/chemosensitivity.